Assertio (ASRT)

• Market cap: $70.7M
• 1 day: 1.65%
• 5 days: 2.08%
• 1 month: -9.58%
• 3 months: -9.37%
• 6 months: 6.24%
• Year to date: -13.54%
• 1 year: -26.5%
• 5 years: -56.25%
• 10 years: -99.05%
• Sector: Healthcare
• Industry: Drug Manufacturers - Specialty & Generic

About: Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older and Zipsor, liquid-filled capsules for relief of mild to moderate pain.

Employees: 30